TickerTalks
Browse all tickers →
TickerTalks›$CIRC
CICIRC

Circle8 Group, Inc.

$CIRC·$65M·Medical - Pharmaceuticals·Healthcare
$0.66+7.2%1Y-20.2%
Mentions · last 7 days
2026-08-17: 4 posts2026-08-18: 2 posts2026-08-19: 6 posts2026-08-20: 31 posts2026-08-21: 4 posts2026-08-22: 0 posts2026-08-23: 0 posts47+9%
Price updated 9m ago·X counts updated 22h ago
CICIRC
$CIRCCircle8 Group, Inc.
$0.66+7.21%47 posts+9%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $CIRC, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Comeback attemptWinding up for a moveAI verdict · as of 2026-08-22

Trading in a tight range and building pressure — a move looks likely soon, but the direction isn't clear yet.

Circle8 (formerly Atlantic International) just annualized $1.2B first-half revenue at a $65M market cap — the numbers are real, the tape hasn't yet caught them.

Circle8 Group (formerly Atlantic International) is a global technology-and-workforce-solutions platform — technology consulting, staffing and workforce-solutions services for enterprise and government customers. The setup right now is a genuine multi-quarter revenue explosion at a tiny market cap.

  • The revenue engine is genuinely accelerating: H1 2026 revenue hit a record $569.7M (+177% YoY), and Q2 was $319.8M (+210.8% YoY) — the half-year already exceeds full-year 2025, so the growth trajectory is real if unusual.
  • The valuation is arithmetic: at a $65M market cap with a $1.2B+ implied annualized revenue base — that's a fraction of 0.1x forward sales, which is deep-value territory if the revenue is actually sustainable.
  • The Q2 net loss is dominated by one-time items: a Q2 net loss of $86.4M was driven by a one-time $60.4M litigation settlement that also eliminated a $35M Lyneer merger note — the reported loss is largely legal-cleanup, not operating deterioration.

This is a turnaround coiling near multi-quarter lows on the disconnect between operating numbers and market cap; a Q3 print (Nov 5) that confirms the revenue-run-rate sustainability and shows margin normalization restarts the trade meaningfully. What extends the coil is a customer-concentration disclosure or a specific accounting-related concern — the discontinuity between the numbers and the tape is the specific opportunity if the fundamentals hold.

Agrees with X sentimentThe X bullish tone reads the $569.7M first-half revenue and $60.4M one-time litigation settlement correctly; the noise-masking-real-margin-improvement framing is a legitimate read on the cleaned-up P&L.

What to watch: Q3 earnings Nov 5 — revenue-run-rate sustainability and margin normalization. A customer-concentration disclosure or an accounting-related concern extends the coil.

On the calendar: 2026-11-05 — Q3 earnings

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Bullish sentiment5 posts analyzed · as of 2026-08-22

Circle8 Group sentiment is bullish on the numbers. Posters flag record H1 revenue of $569.7M (+177% YoY, already topping full-year 2025), Q2 revenue $319.8M (+210.8% YoY), non-GAAP EPS ($-0.02) improving 90% YoY on a $60.4M one-time litigation settlement drag, and annualization above $1.2B. Traders describe filling on pullbacks and watching for what CIRC can do intraday. No visible bear voice in this window.

Read the AI verdict + X sentiment for $CIRC

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

IT consulting and managed services firm covering AI, cybersecurity, and cloud computing for enterprise and government clients in North America and Europe.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Pharmaceuticals sits in its cycle right now — and what that implies for $CIRC.

Medical - Pharmaceuticals · Healthcare

No material change from last week — Trump's executive order support and DEA rescheduling progress create a viable regulatory pathway while ATAI's pipeline advances toward multiple late-stage data..

What this means for $CIRC

Neutral — IT consulting and managed services firm covering AI, cybersecurity, and cloud computing for enterprise and government clients in North America and Europe; limited read-through from medical - pharmaceuticals macro dynamics to this specific revenue mix.

Industry benchmark

6-name peer basket
+58.9%YTD
+47.9%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 19, 2026$-0.02$-0.17+88.2%
Q1 2026Jun 22, 2026$-0.44$-0.18-144.4%
Q3 2025Nov 14, 2025$-0.20$-0.18-11.1%
Q2 2025Aug 14, 2025$-0.20——
Next earningsThu, Nov 5·consensus EPS $-0.16

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.3×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.—Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-16.2%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.—Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 30.6M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today2.2% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β-2.415-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellJul 1Franke Guus Paul WilhelmCEO308.8K sh$309K

See when $CIRC insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-K/AMaterial agreement (amended)Aug 198-K/A — Item 1.01: Material agreement · Item 3.01: Listing / delisting notice · Item 8.01: Other event
AI summary

Circle8 Group, Inc. (CIRC) filed an amendment (8-K/A No. 1) to an August 7, 2026 original 8-K, amending disclosures under Items 1.01 (Material Definitive Agreement), 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), 8.01 (Other Events), and 9.01 (Exhibits). The combination of a material agreement, a delisting notice, and other events suggests Circle8 is managing a significant corporate restructuring or compliance situation — potentially involving a new financing agreement tied to resolving a Nasdaq/NYSE listing compliance deficiency. The 8-K/A amends a prior filing to correct, clarify, or supplement earlier disclosures. Investors should compare the amendment against the original August 7 filing to identify what specifically changed.

8-KMaterial agreementAug 138-K — Item 1.01: Material agreement · Item 3.01: Listing / delisting notice · Item 8.01: Other event
AI summary

Circle8 Group, Inc. (Englewood Cliffs, NJ; Nasdaq: CIRC), together with its Lyneer operating subsidiaries, entered into a settlement agreement on August 7, 2026 with SPP Credit Advisors LLC (administrative agent for lenders under a Bridge Loan and Term Loan Credit Agreement), resolving outstanding litigation arising from alleged covenant defaults. A key term extinguishes a $35 million convertible promissory note convertible into Circle8 common stock, and the parties agreed to orderly repayment of the loan obligations; IDC Technologies, Inc. was also a party to the dispute. Eliminating the $35 million convertible note removes a significant potential dilution overhang and resolves a material legal risk.

8-KMaterial agreementJul 18-K — Item 1.01: Material agreement · Item 5.02: Officer or director change · Item 5.03: Charter amendment · Item 7.01: Press release / Reg FD
AI summary

Atlantic International Corp (CIRC) appointed Guus Franke as Chief Executive Officer and transitioned Jeffrey Jagid to President, consolidating strategic leadership under Franke while retaining Jagid's operational involvement. The leadership restructuring at the IT services and staffing company may signal a shift in strategic priorities.

8-KPress release / Reg FDJun 258-K — Item 2.02: Earnings release · Item 7.01: Press release / Reg FD · Item 8.01: Other event
AI summary

Atlantic International (CIRC) reported first quarter 2026 revenue of $249.9 million and announced a contract win with the Dutch ICT organization, demonstrating continued momentum in European IT services. The Q1 results and public sector contract win indicate the company is growing its managed services footprint in the Netherlands and broader European market.

8-KOfficer or director changeApr 38-K — Item 2.04: Debt-obligation acceleration · Item 5.02: Officer or director change · Item 8.01: Other event
8-KMaterial agreementMar 268-K — Item 1.01: Material agreement · Item 2.01: Acquisition completed · Item 5.03: Charter amendment
S-3Shelf registrationMar 23S-3
+ 8 other (2 10-Qs · 2 NT 10-Qs · 1 RW · 1 10-K) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Atlantic International (NASDAQ:CIRC) Trading Down 7.8% – Here’s What Happeneddefenseworld.net·4d agoCircle8 Group Delivers Record $569.7 Million First-Half Revenue, Up 177%globenewswire.com·5d agoCircle8 Awarded Two $20 Million Dutch Public Sector Contract Extensions, Demonstrating Positive Commercial Momentum Across the Public Sectorglobenewswire.com·43d agoAtlantic International Relaunches As Circle8, Reflecting Its Evolution Into A Global Technology and Workforce Solutions Platformglobenewswire.com·56d ago

More in Medical - Pharmaceuticals

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$LQDA$CORT$KNSA$PAVS$SGIPF$UCBJF
Voices on X · top 5 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport